Course Information

NEW DATES: FEBRUARY  2020

Application Guidelines

This training is intended for trainees but is open to applications from any graduate student, post-doctoral fellow or faculty member recommended by a PCTC Research Hub.

Three documents are requested for applications:

NHLBI Progenitor Cell Translational Consortium – Clinical Translation Studies

Background

The goal of the NHLBI Progenitor Cell Translational Consortium (PCTC) is to translate advances in progenitor cell biology towards application to heart, lung, and blood diseases. The initiative will focus on the use of progenitor cell-based disease models to understand disease mechanisms and to develop novel therapies, and the application of progenitor cell-based therapies for the treatment of heart, lung, and blood diseases.

NHLBI Progenitor Cell Translational Consortium – Bioinformatics and Data Analysis Support for Clinical Translation Studies

Background

The Progenitor Cell Biology Consortium (PCBC) of the National Heart, Lung, and Blood Institute (NHLBI) performed comprehensive experimental and genomic analyses of iPSC and hESC lines from different laboratories derived using a variety of reprogramming methods.  Culture systems for the cell lines were harmonized. Resulting data are publicly available through Synapse.